A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. - du Bois,A.; Lück,H.; Meier,W.; Adams,H.; Möbus,V.; Costa,S.; Bauknecht,T.; Richter,B.; Warm,M.; Schröder,W.; Olbricht,S.; Nitz,U.; et al. (J Natl Cancer Inst, 2003)